Literature DB >> 35992252

Albumin infusions and decompensated cirrhosis: No longer the elixir of life?

Vladimir Marquez1.   

Abstract

Entities:  

Keywords:  albumin; ascites; cirrhosis; infections; mortality

Year:  2021        PMID： 35992252      PMCID： PMC9202766          DOI： 10.3138/canlivj-2021-0009

Source DB:  PubMed          Journal:  Can Liver J        ISSN： 2561-4444


× No keyword cloud information.
  6 in total

1.  Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.

Authors:  Marco Di Pascoli; Silvano Fasolato; Salvatore Piano; Massimo Bolognesi; Paolo Angeli
Journal:  Liver Int       Date:  2018-10-08       Impact factor: 5.828

2.  Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

Authors:  Elsa Solà; Cristina Solé; Macarena Simón-Talero; Marta Martín-Llahí; José Castellote; Rita Garcia-Martínez; Rebeca Moreira; Maria Torrens; Francisca Márquez; Núria Fabrellas; Gloria de Prada; Patrícia Huelin; Eva Lopez Benaiges; Meritxell Ventura; Marcela Manríquez; André Nazar; Xavier Ariza; Pilar Suñé; Isabel Graupera; Elisa Pose; Jordi Colmenero; Marco Pavesi; Mónica Guevara; Miquel Navasa; Xavier Xiol; Joan Córdoba; Victor Vargas; Pere Ginès
Journal:  J Hepatol       Date:  2018-08-21       Impact factor: 25.083

3.  A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.

Authors:  Louise China; Nick Freemantle; Ewan Forrest; Yiannis Kallis; Stephen D Ryder; Gavin Wright; Andrew J Portal; Natalia Becares Salles; Derek W Gilroy; Alastair O'Brien
Journal:  N Engl J Med       Date:  2021-03-04       Impact factor: 91.245

Review 4.  Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.

Authors:  Rita Garcia-Martinez; Paolo Caraceni; Mauro Bernardi; Pere Gines; Vicente Arroyo; Rajiv Jalan
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

5.  Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality.

Authors:  Rajiv Jalan; Kerstin Schnurr; Rajeshwar P Mookerjee; Sambit Sen; Lisa Cheshire; Stephen Hodges; Vladimir Muravsky; Roger Williams; Gert Matthes; Nathan A Davies
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

6.  Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Authors:  Paolo Caraceni; Oliviero Riggio; Paolo Angeli; Carlo Alessandria; Sergio Neri; Francesco G Foschi; Fabio Levantesi; Aldo Airoldi; Sergio Boccia; Gianluca Svegliati-Baroni; Stefano Fagiuoli; Roberto G Romanelli; Raffaele Cozzolongo; Vito Di Marco; Vincenzo Sangiovanni; Filomena Morisco; Pierluigi Toniutto; Annalisa Tortora; Rosanna De Marco; Mario Angelico; Irene Cacciola; Gianfranco Elia; Alessandro Federico; Sara Massironi; Riccardo Guarisco; Alessandra Galioto; Giorgio Ballardini; Maria Rendina; Silvia Nardelli; Salvatore Piano; Chiara Elia; Loredana Prestianni; Federica Mirici Cappa; Lucia Cesarini; Loredana Simone; Chiara Pasquale; Marta Cavallin; Alida Andrealli; Federica Fidone; Matteo Ruggeri; Andrea Roncadori; Maurizio Baldassarre; Manuel Tufoni; Giacomo Zaccherini; Mauro Bernardi
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.